Abstract
Several important CNS monoamine neurotransmitters have as their precursors simple aromatic amino acids present in dietary protein. For instance, serotonin (5-hydroxytryptamine; 5-HT), the indoleamine neurotransmitter, is formed from the essential amino acid tryptophan, and the catecholamines, dopamine (DA), norepinephrine (NE), and epinephrine (E), are formed from the amino acid tyrosine (Figs. 1, 2). The circulating level of these amino acids changes with meal consumption, dependent on the dietary content of protein, carbohydrate, and fat.1–4 The carrier system that transports these precursor amino acids across the blood-brain barrier is normally unsaturated, and changes in their circulating levels can raise or lower brain tryptophan and tyrosine concentration.5,6 Once in the brain, and in the particular subset of amine-containing neurons, tryptophan and tyrosine can influence the synthesis of their respective neurotransmitters, since the rate-limiting synthetic enzymes are normally unsaturated with respect to substrate or, under certain conditions, may become precursor responsive.7
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fernstrom, J. D., and Wurtman, R. J., 1972, Science 178:414–416.
Gibson, C. J., and Wurtman, R. J., 1977, Biochem. Pharmacol. 26:1137–1142.
Fernstrom, J. D., and Faller, D. V., 1978, J. Neurochem. 30:1531–1538.
Fernstrom, J. D., Wurtman, R. J., Hammarstrom-Wiklund, B., Rand, W. M., Munro, H. N., and Davidson, C. S., 1979, Am. J. Clin. Nutr. 32:1912–1922.
Blasberg, R., and Lajtha, A., 1966, Brain Res. 1:86–104.
Pardridge, W. M., and Oldendorf, W. H., 1977, J. Neurochem. 28:5–12.
Wurtman, R. J., Hefti, F., and Melamed, E., 1981, Pharmacol. Rev. 32:315–335.
Fernstrom, J. D., and Wurtman, R. J., 1971, Nature 234:62–64.
Kaufman, S., 1974, Aromatic Amino Acids in the Brain (G. E. W. Wolstenholme and D. W. Fitzsimons, eds.), Elsevier, Amsterdam, pp. 85–115.
Karobath, M., and Baldessarini, R. J., 1972, Nature 236:206–208.
Bagchi, S. P., and Smith, T. M., 1979, Res. Commun. Chem. Pathol. Pharmacol. 26:447–458.
Gibson, C. J., Deikel, S. M., Young, S. N., and Binik, Y. M., 1982, Psychopharmacology 76:118–121.
McKean, C. M., 1972, Brain Res. 47:469–476.
Yuwiler, A., and Louttit, R. T., 1961, Science 134:831–832.
Thorn, J. C., Victor, T., Pichanick, A. M. E., Hunter, J. C., and Pretorius, L., 1981, South Afr. Med. J. 20:946–949.
McMenamy, R. H., and Oncley, J. L., 1958, J. Biol. Chem. 233:1436–1447.
Yuwiler, A., Oldendorf, W. H., Geller, E., and Braun, L., 1977, J. Neurochem. 28:1015–1023.
Wurtman, R. J., and Pardridge, W. M., 1979, J. Neural Transm. [Suppl.] 15:227–236.
Fernstrom, J. D., and Wurtman, R. J., 1971, Science 173:149–152.
Wurtman, R. J., Larin, F., Mostafapour, S., and Fernstrom, J. D., 1974, Science 185:183–184.
Eccleston, D., Ashcroft, G. W., Crawford, T. B. B., Stanton, J. B., Wood, D., and McTurk, P. H., 1970, J. Neurol. Neurosurg. Psychiatry 33:269–272.
Melamed, E., Glaeser, B., Growdon, J. H., and Wurtman, R. J., 1980, J. Neural Transm. 47:299–306.
Fernstrom, J. D., and Wurtman, R. J., 1971, Science 174:1023–1025.
Fernstrom, J. D., and Wurtman, R. J., 1972, Metabolism 21:337–342.
MacKenzie, R. G., and Trulson, M. E., 1978, J. Neurochem. 30:205–211.
Crandall, E. A., and Fernstrom, J. D., 1980, Diabetes 29:460–466.
Crandall, E. A., Gillis, M. A, and Fernstrom, J. D., 1981, Endocrinology 109:310–312.
Litwack, G., and Diamondstone, T. I., 1962, J. Biol. Chem. 237:469–472.
Green, A. R., Sourkes, T. L., and Young, S. N., 1975, Br. J. Pharmacol. 53:287–292.
Laborit, H., and Thuret, F., 1977, Agressologie 18:83–88.
Curzon, G., 1972, J. Psychiatr. Res. 9:243–252.
Moller, S. E., 1979, Lancet 2:472.
Moller, S. E., 1981, Neuropsychobiology 7:192–200.
Tong, J. H., and Kaufman, S., 1975, J. Biol. Chem. 250:4152–4158.
Ichiyama, A., Nakamura, S., Nishizuka, Y., and Hayaishi, O., 1970, J. Biol. Chem. 245:1699–1709.
Nagatsu, T., Levitt, M., and Udenfriend, S., 1964, J. Biol. Chem. 239:2910–2917.
Joh, T. H., Shikimi, T., Pickel, V. M., and Reis, D. J., 1975, Proc. Natl. Acad. Sci. U.S.A. 72:3575–3579.
Pickel, V. M., Joh, T. H., and Reis, D. J., 1975, Brain Res. 85:295–300.
Lovenberg, W., Weissbach, H., and Udenfriend, S., 1962, J. Biol. Chem. 237:89–93.
Axelrod, J., 1972, Pharm. Rev. 24:233–243.
Hokfelt, T., Fuxe, K., Goldstein, M., and Johansson, O., 1974, Brain Res. 66:235–251.
Koe, B. K., and Weissman, A., 1966, J. Pharmacol. Exp. Ther. 154:499–516.
Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, J. Pharmacol. Exp. Ther. 147:86–95.
Zivkovic, B., Guidotti, A., and Costa, E., 1974, Mol. Pharmacol. 10:727–735.
Roth, R. H., Morgenroth, V. H., and Salzman, P. M., 1975, Naunyn Schmeidebergs Arch Pharmacol 289:327–343.
Morgenroth, V. H., Walters, J. R., and Roth, R. H., 1976, Biochem. Pharmacol. 25:655–661.
Lovenberg, W., Bruckwick, E. A., and Hanbauer, I., 1975, Proc. Natl. Acad. Sci. U.S.A. 72:2955–2958.
Black, I. B., and Reis, D. J., 1975, Brain Res. 84:269–278.
Davis, J. N., and Carlsson, A., 1973, J. Neurochem. 20:913–915.
Davis, J. N., Carlsson, A., MacMillan, V., and Siesjo, B. K., 1973, Science 182:72–74.
Kettler, R., Bartholini, G., and Pletscher, A., 1974, Nature 249:476–478.
West, D. P., and Fillenz, M., 1980, J. Neurochem. 35:1323–1328.
Glowinski, J., Besson, M. J., Cheramy, A., and Thierry, A. M., 1972, Adv. Biochem. Psychopharmacol. 6:93–109.
Carlsson, A., and Lindqvist, M., 1973, J. Neural Transm. 34:79–91.
Carlsson, A., and Lindqvist, M., 1978, Naunyn Schmiedebergs Arch. Pharmacol. 303:157–164.
Eccleston, D., Ashcroft, G. W., and Crawford, T. B. B., 1965, J. Neurochem. 12:493–503.
Moir, A. T. B., and Eccleston, D., 1968, J. Neurochem. 15:1093–1108.
Alousi, A., and Weiner, N., 1966, Proc. Natl. Acad. Sci. U.S.A. 56:1491–1496.
Carlsson, A., Kehr, W., and Lindqvist, M., 1974, Adv. Biochem. Psychopharmacol. 12:135–143.
Joh, T. H., Park, D. H., and Reis, D. J., 1978, Proc. Natl. Acad. Sci. U.S.A. 75:4744–4748.
Letendre, C. H., MacDonnell, P. C., and Guroff, G., 1977, Biochem. Biophys. Res. Commun. 74:891–897.
Weiner, W., Lee, F.-L., Dryer, E., and Barnes, E., 1978, Life Sci. 22:1197–1216.
Masserano, J. M., and Weiner, N., 1979, Mol. Pharmacol. 16:513–528.
Levine, R. A., Kuhn, D. M., and Lovenberg, W., 1979, J. Neurochem. 32:1575–1578.
Gibson, C. J., 1977, Factors Controlling Brain Catecholamine Biosynthesis: Effect of Brain Tyrosine, Ph.D. Thesis, M.I.T., Cambridge.
Gibson, C. J., and Wurtman, R. J., 1978, Life Sci. 22:1399–1406.
Scally, M. C., Ulus, I. H., and Wurtman, R. J., 1977, J. Neural Transm. 41:1–6.
Melamed, E., Hefti, F., and Wurtman, R. J., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:4305–4309.
Sved, A. F., Fernstrom, J. D., and Wurtman, R. J., 1979, Life Sci. 25:1293–1300.
Sved, A. F., and Fernstrom, J. D., 1981, Life Sci. 29:743–748.
Fuller, R. W., and Snoddy, H. D., 1982, J. Pharm. Pharmacol. 34:117–118.
Iuvone, P. M., Galli, C. L., Garrison-Gund, C. K., and Neff, N. H., 1978, Science 202:901–902.
Iuvone, P. M., Galli, C. L., and Neff, N. H., 1978, Mol. Pharmacol. 14:1212–1219.
Gibson, C. J., Watkins, C. J., and Wurtman, R. J., 1982, Retina 2:332–340.
Alonso, R., Agharanya, J. C., and Wurtman, R. J., 1980, J. Neural Transm. 49:31–43.
Ternaux, J. P., Boireau, A., Bourgoin, S., Hamon, M., Hery, F., and Glowinski, J., 1976, Brain Res. 101:533–548.
Growdon, J. H., 1979, Nutrition and the Brain, Volume 3 (R. J. Wurtman and J. J. Wurtman, eds.), Raven Press, New York, pp. 117–181.
Growdon, J. H., and Gibson, C. J., 1982, Current Neurology, Volume 4 (S. H. Appel, ed.), John Wiley & Sons, New York, pp. 117–144.
Young, S. N., and Sourkes, T. L., 1975, Advances in Neurochemistry, Volume 2 (B. W. Agranoff and M. H. Aprison, eds.), Plenum Press, New York, pp. 133–191.
Hartmann, E., 1977, Am. J. Psychiatry 134:366–370.
Modigh, K., 1973, Psychopharmacologia 30:123–134.
Thurmond, J. B., Lasley, S. M., Corking, A. L., and Brown, J. W., 1977, Pharmacol. Biochem. Behav. 6:475–478.
Thurmond, J. B., Kramarcy, N. R., Lasley, S. M., and Brown, J. W., 1980, Pharmacol. Biochem. Behav. 12:525–532.
Lytle, L. D., Messing, R. B., Fisher, L., and Phebus, L., 1975, Science 190:692–694.
King, R. B., 1980, J. Neurosurg. 53:44–52.
Hosobuchi, Y., Lamb, S., and Bascom, D., 1980, Pain 9:161–169.
Gibbons, J. L., Burr, G. A., Bridger, W. H., and Leibowitz, S. F., 1979, Brain Res. 169:139–153.
Latham, C. J., and Blundell, J. E., 1979, Life Sci. 24:1971–1978.
Wurtman, J. J., and Wurtman, R. J., 1979, Life Sci. 24:895–904.
Ashley, D. V. M., and Anderson, G. H., 1975, J. Nutr. 105:1412–1421.
Sved, A. F., Fernstrom, J. D., and Wurtman, R. J., 1979, Proc. Natl. Acad. Sci. U.S.A. 76:3511–3514.
Osumi, Y., Tanaka, C., and Takaori, S., 1974, Jpn. J. Pharmacol. 24:715–720.
Yamori, Y., Fujiwara, M., Horie, R., and Lovenberg, W., 1980, Eur. J. Pharmacol. 68:201–204.
Conlay, L. A., Maher, T. J., and Wurtman, R. J., 1981, Science 212:559–560.
Gelenberg, A. J., Wojcik, J. D., Growdon, J. H., Sved, A. F., and Wurtman, R. J., 1980, Am. J. Psychiatry 137:622–623.
Growdon, J. H., and Melamed, E., 1980, Neurology (N.Y.) 30:396.
Gallager, W., and Aghajanian, G. K., 1976, Neuropharmacology 15:149–158.
Karobath, M., Diaz, J. L., and Huttunen, M. O., 1971, Eur. J. Pharmacol. 14:393–396.
Chiel, H. J., and Wurtman, R. J., 1981, Science 213:676–678.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Gibson, C.J. (1985). Control of Monoamine Synthesis by Precursor Availability. In: Lajtha, A. (eds) Neurochemical Systems. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7018-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7018-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7020-8
Online ISBN: 978-1-4684-7018-5
eBook Packages: Springer Book Archive